semaglutide tirzepatide weight loss vs Semaglutide: 2026 Clinical Comparison Tirzepatide vs. Semaglutide: Which Weight
Description
Medicine 96 , e8952 (2017)
Key findings from the SURMOUNT-OSA trial The SURMOUNT-OSA trial evaluated tirzepatide versus placebo in adults with moderate-to-severe OSA (AHI 15) and obesity, including both CPAP users and non-users
Clinical trials demonstrating Mounjaro/Zepbounds effectiveness (SURMOUNT program) ran for approximately 72 weeks, with participants losing an average of 22.5% of total body weight
If you want healthy weight loss that lasts, you must lose weight properly
